Address
Sree Ganesh
2473 E Block
Sahakara Nagar
Bangalore, KA
560092, India
Contact
Venkatasubramanian Narayanan+919945274057
venkat@peptris.com
Website
Accelerating Drug Discovery using AI/ML
pepAI predicts novel and diverse molecules accurately and accelerates the pre-clinical discovery
a)Ultra large virtual screening b)Agnostic to therapies and targets(human, bacterial, viral) c)De-novo molecules – novel IP with desired properties
- Antimicrobial compound/strategy
- Infection prevention
- Antimicrobial stewardship
- Microbial diagnostics
- Removal antibiotics/bacteria
Microorganisms:
- Bacteria
- Viruses
- Fungi
- Yeasts
- Parasites
Application:
- Human
- Veterinary
- AgriFood
- Environmental
- Other
Development stage:
- Development
- Validation
- Research
- Market entry
- Marketed product
- Company
- Academia
- Institute
- NGO
- Government
Partnering:
- Co-develop
- Outsource
- Joint Venture
- License
- Sell
Funding organisation:
- OTHER / NA
- CARB-X
- FIND
- GARDP
- REPAIR
Infectious disease area:
- UTI
- STI
- BSI
- RTI
- GII
- SSTI
- CNSI
- IAI
- SSI
Geographic origin:
- Eurasia
- North America
- South America
- Africa
- Oceania
Biotech or Pharma companies with strong biology capabilites seeking partners for HIT identification, Lead generation and lead optimization of novel chemical scaffolds for their protein targets.
Peptris is an AI/ML company creating a versatile AI platform (pepAI) to enhance efficiencies by 10x or more across the drug discovery cascade.
pepAI can scan over a 100Million molecules for diverse applications including – activity prediction on mutated protein in drug resistant organisms thus accelerating drug discovery for AMR
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!